PALO ALTO Security Advisory
Published Date: Not specified
CVE: CVE-2026-0295
Advisory Summary
🔎 ⚠️ CVE-2026-0295 — GlobalProtect (macOS) Local Privilege Escalation ⚠️
Palo Alto Networks discloses CVE-2026-0295, a MEDIUM-severity issue affecting the GlobalProtect app on macOS. The vulnerability is a race condition that can enable local privilege escalation under specific circumstances. While the impact is localized to the affected host, it can be particularly concerning in environments where user workstations are tightly integrated with VPN access and endpoint trust boundaries.
- Endpoint escalation risk: A successful local attacker may gain elevated privileges on the macOS device.
- VPN-adjacent exposure: GlobalProtect is commonly installed on corporate systems; misconfigurations or local access scenarios can amplify business impact.
- Race-condition complexity: Exploitability depends on timing and local conditions—meaning risk may be uneven across environments, but still real for targeted attacks.
- Patch cadence urgency: Treat this as a workstation security fix—not just a “VPN app” update.
- Local threat models: If you assume adversaries may already have user-level access (malicious insider, compromised accounts, or malware footholds), the practical risk increases.
- Regression testing needed: Validate post-update behavior for GlobalProtect connectivity and auth workflows on affected macOS versions.
âś… Informations (Actionable recommendations)
1. Identify affected systems: Inventory macOS endpoints running the GlobalProtect app and determine which versions are exposed to CVE-2026-0295.
2. Apply vendor patches immediately: Upgrade GlobalProtect to the fixed release per Palo Alto Networks guidance.
3. Harden local access paths: Reduce likelihood of local attackers by strengthening endpoint hardening (least privilege, OS hardening, application permissions).
4. Monitor for suspicious activity: Look for unusual privilege changes or anomalous local process behavior following updates/attempted exploitation.
-2026-0295
Reference: Vendor Advisory